Trade AGEN stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Agenus Inc. (AGEN) is trading at US$7.54, down 0.04% today as of Oct 9, 12:44 EDT. The company has a market capitalisation of US$364.13M. Over the past 52 weeks, AGEN has traded between US$2.71 and US$10.31. On Syfe you can trade AGEN with $0 commission and add it to your watchlist.
| Previous close | US$7.54 |
|---|---|
| Market cap | US$364.13M |
| 52-week range | US$2.71 – US$10.31 |
| Volume | 1.21M |
| Exchange | US |
Agenus Inc.
Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.
Year: 2000
Agenus Files for Resale of Up to 78 Million Shares
Aug 7, 8:51 PM · MT Newswires
--B. Riley Adjusts Agenus Price Target to $14 From $8, Maintains Buy Rating
Jul 30, 2:29 PM · MT Newswires
Agenus Inc. (AGEN) stock is trading at US$7.54, -0.04% from the previous close of US$7.54.
The market cap for Agenus Inc. (AGEN) stock is approximately US$364.13M.
The 52-week high for Agenus Inc. (AGEN) stock is US$10.31.
The 52-week low for Agenus Inc. (AGEN) stock is US$2.71.
Agenus Inc. (AGEN) does not currently pay a dividend.
Stay on top of AGEN
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
